Telix Pharmaceuticals Ltd (TLX, TLPPF) (CIK 0002007191) (TLX)
Activity window: Oct. 25, 2025 to Oct. 24, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Apr. 23, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 23, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Telix Pharmaceuticals Limited's Form 20-F for the fiscal year ended December 31, 2025. They remind the company and its management of their resp… | Read Filing EDGAR |
| Apr. 17, 2026 | CORRESP | Concern from SEC | Moderate | Telix Pharmaceuticals Limited responded to a comment from the SEC regarding their use of Adjusted EBITDAR, a non-IFRS financial measure. The SEC requested clarification on how the… | Read Filing EDGAR |
| Apr. 3, 2026 | UPLOAD | Concern from SEC | High | The SEC has limited its review of Telix Pharmaceuticals Limited's Form 20-F for the fiscal year ended December 31, 2025, focusing specifically on the financial statements and rela… | Read Filing EDGAR |